Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.
- Conditions
- healthy adult
- Registration Number
- JPRN-UMIN000016026
- Lead Sponsor
- Center for iPS Cell Research and Application (CiRA), Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1)Enrolling related studies of generating iPSC banks 2)The following viral infection: Hepatic Virus B Hepatic Virus C Human Immunodeficiency Virus Human T-cell leukemia virus Human parvovirus B19 Cytomegalovirus 3)The following microbial infection: Treponema pallidum West e Virus Chlamydiaceae Genus Neisseria Mycobacterium Malaria parasites(Plasmodium spp.) Babesia Trypanosoma cruzi Leishmania Trypanosoma brucei 4)Malignant neoplasm 5)Transmissible spongiform encephalopathy (including suspected case), Dementia or cognitive impairment, Stroke, Seizure 6)The following conditions: Particular or genetic/hereditary disorders Severe or uncontrolled metabolic or endocrinal disorders Connective tissue diseases Severe or uncontrolled hematologic diseases Severe or uncontrolled hepatic disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Charactrization of iPS cells derived from HLA homozyougous donor.
- Secondary Outcome Measures
Name Time Method